{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-140053","form_type":"8-K","ticker":"BCAB","cik":"0001826892","company_name":"BioAtla, Inc.","filed_at":"2026-04-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.030600+00:00","generated_at":"2026-05-15T07:52:10.584337+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"BioAtla to effect 1-for-50 reverse stock split via merger effective April 6, 2026","bullets":["Certificate of Merger filed April 2, 2026; merger effective April 6, 2026 at 12:01 a.m. Eastern Time.","Every 50 outstanding shares of common stock will be converted into 1 share.","Merger with wholly owned subsidiary BA Merger Sub, Inc.; BioAtla is the surviving corporation.","No change to company name or business; charter remains as in effect prior to merger."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-140053","json":"https://secwatch.observer/filing/0001193125-26-140053.json","markdown":"https://secwatch.observer/filing/0001193125-26-140053.md","text":"https://secwatch.observer/filing/0001193125-26-140053.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826892/000119312526140053/0001193125-26-140053-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826892/000119312526140053/bcab-20260402.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T07:52:10.584337+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}